Home > > > Report Detail

Global Type 1 Diabetes (T1D) Market Insights, Forecast to 2025

Publisher Name :
Date: 05-Jun-2019
No. of pages: 113
Inquire Before Buying

Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person's pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body's immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.

Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D's serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.

The global Type 1 Diabetes (T1D) market is valued at 1960 million US$ in 2018 and will reach 2810 million US$ by the end of 2025, growing at a CAGR of 4.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Type 1 Diabetes (T1D) market based on company, product type, end user and key regions.

This report studies the global market size of Type 1 Diabetes (T1D) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Type 1 Diabetes (T1D) in these regions.

This research report categorizes the global Type 1 Diabetes (T1D) market by top players/brands, region, type and end user. This report also studies the global Type 1 Diabetes (T1D) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Novo Nordisk

- Sanofi

- Eli Lilly

- Merck

- Boehringer Ingelheim

- Samsung Bioepis

- Biocon

- Astellas

- Janssen

- Bristol-Myers Squibb

- Lexicon

- Sanofi

Market size by Product

- Rapid Acting Insulin Analogs

- Long Acting Insulin Analogs

- Premix Insulin Analogs

Market size by End User

- Children

- Adults

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Type 1 Diabetes (T1D) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Type 1 Diabetes (T1D) market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Type 1 Diabetes (T1D) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Type 1 Diabetes (T1D) submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Type 1 Diabetes (T1D) are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Type 1 Diabetes (T1D) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Type 1 Diabetes (T1D) Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Type 1 Diabetes (T1D) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Type 1 Diabetes (T1D) Market Size Growth Rate by Product
1.4.2 Rapid Acting Insulin Analogs
1.4.3 Long Acting Insulin Analogs
1.4.4 Premix Insulin Analogs
1.5 Market by End User
1.5.1 Global Type 1 Diabetes (T1D) Market Size Growth Rate by End User
1.5.2 Children
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Type 1 Diabetes (T1D) Market Size
2.1.1 Global Type 1 Diabetes (T1D) Revenue 2014-2025
2.1.2 Global Type 1 Diabetes (T1D) Sales 2014-2025
2.2 Type 1 Diabetes (T1D) Growth Rate by Regions
2.2.1 Global Type 1 Diabetes (T1D) Sales by Regions
2.2.2 Global Type 1 Diabetes (T1D) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Type 1 Diabetes (T1D) Sales by Manufacturers
3.1.1 Type 1 Diabetes (T1D) Sales by Manufacturers
3.1.2 Type 1 Diabetes (T1D) Sales Market Share by Manufacturers
3.1.3 Global Type 1 Diabetes (T1D) Market Concentration Ratio (CR5 and HHI)
3.2 Type 1 Diabetes (T1D) Revenue by Manufacturers
3.2.1 Type 1 Diabetes (T1D) Revenue by Manufacturers (2014-2019)
3.2.2 Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2014-2019)
3.3 Type 1 Diabetes (T1D) Price by Manufacturers
3.4 Type 1 Diabetes (T1D) Manufacturing Base Distribution, Product Types
3.4.1 Type 1 Diabetes (T1D) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Type 1 Diabetes (T1D) Product Type
3.4.3 Date of International Manufacturers Enter into Type 1 Diabetes (T1D) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Type 1 Diabetes (T1D) Sales by Product
4.2 Global Type 1 Diabetes (T1D) Revenue by Product
4.3 Type 1 Diabetes (T1D) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Type 1 Diabetes (T1D) Breakdown Data by End User
6 North America
6.1 North America Type 1 Diabetes (T1D) by Countries
6.1.1 North America Type 1 Diabetes (T1D) Sales by Countries
6.1.2 North America Type 1 Diabetes (T1D) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Type 1 Diabetes (T1D) by Product
6.3 North America Type 1 Diabetes (T1D) by End User
7 Europe
7.1 Europe Type 1 Diabetes (T1D) by Countries
7.1.1 Europe Type 1 Diabetes (T1D) Sales by Countries
7.1.2 Europe Type 1 Diabetes (T1D) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Type 1 Diabetes (T1D) by Product
7.3 Europe Type 1 Diabetes (T1D) by End User
8 Asia Pacific
8.1 Asia Pacific Type 1 Diabetes (T1D) by Countries
8.1.1 Asia Pacific Type 1 Diabetes (T1D) Sales by Countries
8.1.2 Asia Pacific Type 1 Diabetes (T1D) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Type 1 Diabetes (T1D) by Product
8.3 Asia Pacific Type 1 Diabetes (T1D) by End User
9 Central & South America
9.1 Central & South America Type 1 Diabetes (T1D) by Countries
9.1.1 Central & South America Type 1 Diabetes (T1D) Sales by Countries
9.1.2 Central & South America Type 1 Diabetes (T1D) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Type 1 Diabetes (T1D) by Product
9.3 Central & South America Type 1 Diabetes (T1D) by End User
10 Middle East and Africa
10.1 Middle East and Africa Type 1 Diabetes (T1D) by Countries
10.1.1 Middle East and Africa Type 1 Diabetes (T1D) Sales by Countries
10.1.2 Middle East and Africa Type 1 Diabetes (T1D) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Type 1 Diabetes (T1D) by Product
10.3 Middle East and Africa Type 1 Diabetes (T1D) by End User
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Company Business Overview
11.1.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novo Nordisk Type 1 Diabetes (T1D) Products Offered
11.1.5 Novo Nordisk Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Type 1 Diabetes (T1D) Products Offered
11.2.5 Sanofi Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Company Business Overview
11.3.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Eli Lilly Type 1 Diabetes (T1D) Products Offered
11.3.5 Eli Lilly Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Business Overview
11.4.3 Merck Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck Type 1 Diabetes (T1D) Products Offered
11.4.5 Merck Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 Samsung Bioepis
11.6.1 Samsung Bioepis Company Details
11.6.2 Company Business Overview
11.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Samsung Bioepis Type 1 Diabetes (T1D) Products Offered
11.6.5 Samsung Bioepis Recent Development
11.7 Biocon
11.7.1 Biocon Company Details
11.7.2 Company Business Overview
11.7.3 Biocon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Biocon Type 1 Diabetes (T1D) Products Offered
11.7.5 Biocon Recent Development
11.8 Astellas
11.8.1 Astellas Company Details
11.8.2 Company Business Overview
11.8.3 Astellas Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Astellas Type 1 Diabetes (T1D) Products Offered
11.8.5 Astellas Recent Development
11.9 Janssen
11.9.1 Janssen Company Details
11.9.2 Company Business Overview
11.9.3 Janssen Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Janssen Type 1 Diabetes (T1D) Products Offered
11.9.5 Janssen Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Company Business Overview
11.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Products Offered
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Lexicon
11.12 Sanofi
12 Future Forecast
12.1 Type 1 Diabetes (T1D) Market Forecast by Regions
12.1.1 Global Type 1 Diabetes (T1D) Sales Forecast by Regions 2019-2025
12.1.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Regions 2019-2025
12.2 Type 1 Diabetes (T1D) Market Forecast by Product
12.2.1 Global Type 1 Diabetes (T1D) Sales Forecast by Product 2019-2025
12.2.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Product 2019-2025
12.3 Type 1 Diabetes (T1D) Market Forecast by End User
12.4 North America Type 1 Diabetes (T1D) Forecast
12.5 Europe Type 1 Diabetes (T1D) Forecast
12.6 Asia Pacific Type 1 Diabetes (T1D) Forecast
12.7 Central & South America Type 1 Diabetes (T1D) Forecast
12.8 Middle East and Africa Type 1 Diabetes (T1D) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Type 1 Diabetes (T1D) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Type 1 Diabetes (T1D) Product Picture
Table Type 1 Diabetes (T1D) Market Segments
Table Key Manufacturers Type 1 Diabetes (T1D) Covered
Table Global Type 1 Diabetes (T1D) Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Type 1 Diabetes (T1D) Sales Market Share by Product 2014-2025
Figure Rapid Acting Insulin Analogs Product Picture
Table Major Manufacturers of Rapid Acting Insulin Analogs
Figure Long Acting Insulin Analogs Product Picture
Table Major Manufacturers of Long Acting Insulin Analogs
Figure Premix Insulin Analogs Product Picture
Table Major Manufacturers of Premix Insulin Analogs
Table Global Type 1 Diabetes (T1D) Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Children
Figure Adults
Figure Type 1 Diabetes (T1D) Report Years Considered
Figure Global Type 1 Diabetes (T1D) Market Size 2014-2025 (Million US$)
Figure Global Type 1 Diabetes (T1D) Sales 2014-2025 (K MT)
Table Global Type 1 Diabetes (T1D) Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Type 1 Diabetes (T1D) Sales by Regions 2014-2019 (K MT)
Table Global Type 1 Diabetes (T1D) Sales Market Share by Regions 2014-2019
Figure Global Type 1 Diabetes (T1D) Sales Market Share by Regions 2014-2019
Figure 2018 Global Type 1 Diabetes (T1D) Sales Market Share by Regions
Table Global Type 1 Diabetes (T1D) Revenue by Regions 2014-2019 (Million US$)
Table Global Type 1 Diabetes (T1D) Revenue Market Share by Regions 2014-2019
Figure Global Type 1 Diabetes (T1D) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Type 1 Diabetes (T1D) Revenue Market Share by Regions
Table Global Type 1 Diabetes (T1D) Sales by Manufacturers (2014-2019) (K MT)
Table Global Type 1 Diabetes (T1D) Sales Share by Manufacturers (2014-2019)
Figure Global Type 1 Diabetes (T1D) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Type 1 Diabetes (T1D) Revenue by Manufacturers (2014-2019) (Million USD)
Table Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2014-2019)
Figure Type 1 Diabetes (T1D) Value Share by Manufacturers in 2018
Table Key Manufacturers Type 1 Diabetes (T1D) Price (2014-2019) (USD/MT)
Table Type 1 Diabetes (T1D) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Type 1 Diabetes (T1D) Product Type
Table Date of International Manufacturers Enter into Type 1 Diabetes (T1D) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Type 1 Diabetes (T1D) Sales by Product (2014-2019) (K MT)
Table Global Type 1 Diabetes (T1D) Sales Share by Product (2014-2019)
Figure Global Type 1 Diabetes (T1D) Sales Market Share by Product (2014-2019)
Figure Global Type 1 Diabetes (T1D) Sales Market Share by Product in 2018
Table Global Type 1 Diabetes (T1D) Revenue by Product (2014-2019) (Million US$)
Table Global Type 1 Diabetes (T1D) Revenue Share by Product (2014-2019)
Figure Global Type 1 Diabetes (T1D) Revenue Market Share by Product (2014-2019)
Figure Global Type 1 Diabetes (T1D) Revenue Market Share by Product in 2018
Table Type 1 Diabetes (T1D) Price by Product 2014-2019 (USD/MT)
Table Global Type 1 Diabetes (T1D) Sales by End User (2014-2019) (K MT)
Table Global Type 1 Diabetes (T1D) Sales Share by End User (2014-2019)
Figure Global Sales Type 1 Diabetes (T1D) Market Share by End User (2014-2019)
Figure Global Sales Type 1 Diabetes (T1D) Market Share by End User in 2018
Figure North America Type 1 Diabetes (T1D) Sales Growth Rate 2014-2019 (K MT)
Figure North America Type 1 Diabetes (T1D) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Type 1 Diabetes (T1D) Sales by Countries (2014-2019) (K MT)
Table North America Type 1 Diabetes (T1D) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Type 1 Diabetes (T1D) Sales Market Share by Countries
Table North America Type 1 Diabetes (T1D) Revenue by Countries (2014-2019) (Million US$)
Table North America Type 1 Diabetes (T1D) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Type 1 Diabetes (T1D) Revenue Market Share by Countries
Figure United States Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure United States Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Canada Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Type 1 Diabetes (T1D) Sales by Product (2014-2019) (K MT)
Table North America Type 1 Diabetes (T1D) Sales Market Share by Product (2014-2019)
Figure 2018 North America Type 1 Diabetes (T1D) Market Share by Product
Table North America Type 1 Diabetes (T1D) Sales by End User (2014-2019) (K MT)
Table North America Type 1 Diabetes (T1D) Sales Market Share by End User (2014-2019)
Figure 2018 North America Type 1 Diabetes (T1D) Market Share by End User
Figure Europe Type 1 Diabetes (T1D) Sales Growth Rate 2014-2019 (K MT)
Figure Europe Type 1 Diabetes (T1D) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Type 1 Diabetes (T1D) Sales by Countries (2014-2019) (K MT)
Table Europe Type 1 Diabetes (T1D) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Type 1 Diabetes (T1D) Sales Market Share by Countries
Table Europe Type 1 Diabetes (T1D) Revenue by Countries (2014-2019) (Million US$)
Table Europe Type 1 Diabetes (T1D) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Type 1 Diabetes (T1D) Revenue Market Share by Countries
Figure Germany Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Germany Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure France Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure UK Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Italy Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Russia Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Type 1 Diabetes (T1D) Sales by Product (2014-2019) (K MT)
Table Europe Type 1 Diabetes (T1D) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Type 1 Diabetes (T1D) Market Share by Product
Table Europe Type 1 Diabetes (T1D) Sales by End User (2014-2019) (K MT)
Table Europe Type 1 Diabetes (T1D) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Type 1 Diabetes (T1D) Market Share by End User
Figure Asia Pacific Type 1 Diabetes (T1D) Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Type 1 Diabetes (T1D) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Type 1 Diabetes (T1D) Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Countries
Table Asia Pacific Type 1 Diabetes (T1D) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Type 1 Diabetes (T1D) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Type 1 Diabetes (T1D) Revenue Market Share by Countries
Figure China Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure China Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Japan Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Korea Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure India Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Australia Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Type 1 Diabetes (T1D) Sales by Product (2014-2019) (K MT)
Table Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Type 1 Diabetes (T1D) Market Share by Product
Table Asia Pacific Type 1 Diabetes (T1D) Sales by End User (2014-2019) (K MT)
Table Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Type 1 Diabetes (T1D) Market Share by End User
Figure Central & South America Type 1 Diabetes (T1D) Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Type 1 Diabetes (T1D) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Type 1 Diabetes (T1D) Sales by Countries (2014-2019) (K MT)
Table Central & South America Type 1 Diabetes (T1D) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Type 1 Diabetes (T1D) Sales Market Share by Countries
Table Central & South America Type 1 Diabetes (T1D) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Type 1 Diabetes (T1D) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Type 1 Diabetes (T1D) Revenue Market Share by Countries
Figure Brazil Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Type 1 Diabetes (T1D) Sales by Product (2014-2019) (K MT)
Table Central & South America Type 1 Diabetes (T1D) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Type 1 Diabetes (T1D) Market Share by Product
Table Central & South America Type 1 Diabetes (T1D) Sales by End User (2014-2019) (K MT)
Table Central & South America Type 1 Diabetes (T1D) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Type 1 Diabetes (T1D) Market Share by End User
Figure Middle East and Africa Type 1 Diabetes (T1D) Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Type 1 Diabetes (T1D) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Type 1 Diabetes (T1D) Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Countries
Table Middle East and Africa Type 1 Diabetes (T1D) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Type 1 Diabetes (T1D) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Type 1 Diabetes (T1D) Revenue Market Share by Countries
Figure GCC Countries Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Type 1 Diabetes (T1D) Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Type 1 Diabetes (T1D) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Type 1 Diabetes (T1D) Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Type 1 Diabetes (T1D) Market Share by Product
Table Middle East and Africa Type 1 Diabetes (T1D) Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Type 1 Diabetes (T1D) Market Share by End User
Table Novo Nordisk Company Details
Table Novo Nordisk Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Merck Company Details
Table Merck Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Samsung Bioepis Company Details
Table Samsung Bioepis Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Samsung Bioepis Recent Development
Table Biocon Company Details
Table Biocon Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Biocon Recent Development
Table Astellas Company Details
Table Astellas Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Astellas Recent Development
Table Janssen Company Details
Table Janssen Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Janssen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Lexicon Company Details
Table Sanofi Company Details
Table Global Type 1 Diabetes (T1D) Sales Forecast by Regions 2019-2025 (K MT)
Table Global Type 1 Diabetes (T1D) Sales Market Share Forecast by Regions 2019-2025
Table Global Type 1 Diabetes (T1D) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Type 1 Diabetes (T1D) Revenue Market Share Forecast by Regions 2019-2025
Table Global Type 1 Diabetes (T1D) Sales Forecast by Product 2019-2025 (K MT)
Table Global Type 1 Diabetes (T1D) Sales Market Share Forecast by Product 2019-2025
Table Global Type 1 Diabetes (T1D) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Type 1 Diabetes (T1D) Revenue Market Share Forecast by Product 2019-2025
Table Global Type 1 Diabetes (T1D) Sales Forecast by End User 2019-2025 (K MT)
Table Global Type 1 Diabetes (T1D) Sales Market Share Forecast by End User 2019-2025
Figure North America Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Type 1 Diabetes (T1D) Value Chain
Table Type 1 Diabetes (T1D) Customers List
Table Type 1 Diabetes (T1D) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs